189 related articles for article (PubMed ID: 7670397)
41. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
42. High dose therapy and autologous bone marrow versus blood cell rescue. South Island Bone Marrow Transplant Unit.
Hill GR; Inder A; Patton WN; Hart DN
N Z Med J; 1996 Feb; 109(1016):45-8. PubMed ID: 8598936
[TBL] [Abstract][Full Text] [Related]
43. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
[TBL] [Abstract][Full Text] [Related]
44. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
45. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.
Lowdell MW; Ray N; Craston R; Corbett T; Deane M; Prentice HG
Bone Marrow Transplant; 1997 May; 19(9):891-7. PubMed ID: 9156262
[TBL] [Abstract][Full Text] [Related]
46. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
[TBL] [Abstract][Full Text] [Related]
47. Quantity and origin of transplanted autologous blood cells are independent factors associated with speed of postransplant hematological reconstitution.
Rogulj D; Batinić D; Nemet D; Petrovecki M
Croat Med J; 1999 Sep; 40(3):404-8. PubMed ID: 10411969
[TBL] [Abstract][Full Text] [Related]
48. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
Hanenberg H; Dilloo D; Laws HJ; Zessack N; Heyll A; Burdach S
Exp Hematol; 1995 Dec; 23(14):1543-52. PubMed ID: 8542945
[TBL] [Abstract][Full Text] [Related]
49. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
50. Outcome of autologous rescue after failed engraftment of allogeneic marrow.
Mehta J; Powles R; Singhal S; Horton C; Treleaven J
Bone Marrow Transplant; 1996 Feb; 17(2):213-7. PubMed ID: 8640169
[TBL] [Abstract][Full Text] [Related]
51. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
Bone Marrow Transplant; 1999 Sep; 24(6):637-40. PubMed ID: 10490729
[TBL] [Abstract][Full Text] [Related]
52. Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study.
Jorgensen H; Hokland P; Jensen T; Basse P; Hokland M
Nat Immun; 1995; 14(3):164-72. PubMed ID: 8832900
[TBL] [Abstract][Full Text] [Related]
53. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
[TBL] [Abstract][Full Text] [Related]
54. A novel approach to purging of leukemia by activation of bone marrow with interleukin 2.
Charak BS; Malloy B; Agah R; Mazumder A
Bone Marrow Transplant; 1990 Sep; 6(3):193-8. PubMed ID: 2252959
[TBL] [Abstract][Full Text] [Related]
55. Generation and characterization of IL-2-activated bone marrow cells as a potent graft vs tumor effector in transplantation.
Agah R; Malloy B; Kerner M; Mazumder A
J Immunol; 1989 Nov; 143(9):3093-9. PubMed ID: 2809219
[TBL] [Abstract][Full Text] [Related]
56. GM-CSF administration enhances granulocytic recovery in purged autologous bone marrow transplantation for acute lymphoblastic leukemia.
Sureda A; Canals C; Badell I; Nomdedeu J; Llácer M; Brunet S; Sierra J; Grañena A; Cubells J; Domingo-Albós A
Prog Clin Biol Res; 1992; 377():315-20. PubMed ID: 1438428
[No Abstract] [Full Text] [Related]
57. Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia.
Ozsahin H; Fabrega S; Douay L; Barbu V; Gorin NC
Nouv Rev Fr Hematol (1978); 1990; 32(5):353-5. PubMed ID: 2099411
[TBL] [Abstract][Full Text] [Related]
58. Interleukin 2 immediately after autologous bone marrow transplantation for acute lymphoblastic leukemia--a phase I study.
Weisdorf DJ; Anderson PM; Blazar BR; Uckun FM; Kersey JH; Ramsay NK
Transplantation; 1993 Jan; 55(1):61-6. PubMed ID: 8420066
[TBL] [Abstract][Full Text] [Related]
59. Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
Margolin KA; Wright C; Forman SJ
Leukemia; 1997 May; 11(5):723-8. PubMed ID: 9180298
[TBL] [Abstract][Full Text] [Related]
60. Autologous bone marrow transplantation after in vitro purging with monoclonal antibodies and complement in acute lymphoblastic leukemia.
Perez-Oteyza J; Larana JG; Brieva J; Roldan E; Odriozola J; Maldonado M; Otheo E; Munoz A; Bootello A; Navarro JL
Prog Clin Biol Res; 1992; 377():163-8. PubMed ID: 1438412
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]